You just read:

Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Women's Health Market

News provided by

Nautilus Neurosciences, Inc.

Oct 06, 2010, 08:30 ET